Company Description
Ending breast cancer is top priority at EndoCeutics. The trial-phase biopharmaceutical company develops hormone therapies for treating and...
Key EndoCeutics Financials
| Company Type | Private - NASDAQ (GM): ENCX Proposed Main Headquarters |
|---|---|
| Fiscal Year-End | December# |
| 2007 Sales (mil.) | $1.1 |
| 2007 Employees | 1 |
More EndoCeutics Financials (4 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about EndoCeutics's competition across multiple industries
Top EndoCeutics Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
EndoCeutics Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| President, CEO, Chief Scientific Officer, and Director | Fernand Labrie | Network | E-mail |
| CFO | Claude Doré | Network | E-mail |
| COO | Jean-Denis Dubois | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
